Ads
related to: sickle cell crisis- Learn About Treatment
Learn About the Treatment Journey.
Watch the Video to Learn More.
- Patient FAQs
Get Answers to Common Questions.
Understand the Potential Risks.
- Safety and Side Effects
Review the Important Safety
Information & Side Effects.
- View Discussion Guides
Download Treatment Brochures,
Discussion Guides, and More.
- Patient Information
View Important Patient Information.
Understand the Treatment.
- Find an ATC
Find an Authorized Treatment Center
On the Official Patient Website.
- Learn About Treatment
Search results
Results From The WOW.Com Content Network
(Reuters) -U.S. drugmaker Pfizer said on Wednesday it is withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks of a painful complication and ...
It is used when the patient's hemoglobin is much lower than normal, for example an aplastic crisis. Exchange transfusion. Exchange transfusion involves removal of the patient’s blood and replacement with donor red blood cells. It is used to treat life-threatening complications of sickle cell disease such as stroke or acute chest crisis.
Proliferative sickle retinopathy is the most severe ocular complication of sickle cell disease. Even though PSCR begins in the first decade of life, the condition remains asymptomatic and unnoticed until visual symptoms occur due to vitreous hemorrhage or retinal detachment.
A similar relationship exists between malaria and sickle-cell disease. One theory to explain this is that cells infected with the Plasmodium parasite are cleared more rapidly by the spleen . This phenomenon might give G6PD deficiency carriers an evolutionary advantage by increasing their fitness in malarial endemic environments.
Sickle cell-beta thalassemia is an inherited blood disorder. The disease may range in severity from being relatively benign and like sickle cell trait to being similar to sickle cell disease . [ 1 ] [ 2 ]
It is possible for a person to have both the gene for hemoglobin S (the form associated with sickle cell anemia) and the gene for hemoglobin C; this state is called hemoglobin SC disease, and is generally more severe than hemoglobin C disease, but milder than sickle cell anemia. [2]
Crizanlizumab, sold under the brand name Adakveo among others, is a monoclonal antibody medication that binds to P-selectin. [3] It is a medication used to reduce the frequency of vaso-occlusive crisis in people aged 16 years and older who have sickle cell anemia.
The FDA approved a new treatment for sickle cell disease. ... He had suffered from chronic fatigue since he was a young child and would end up in the hospital every year with a pain crisis ...
Ad
related to: sickle cell crisis